DUSP9 and head and neck squamous cell carcinoma: In conclusion, our study demonstrates that DUSP9 is up-regulated in human HNSCC and promotes tumor progression, suggested that DUSP9 may serve as a biomarker for HNSCC prognosis and a potential target for HNSCC treatment.